+1-888-308-5802     
News Contact Us

Hikma and Arecor ink new deal to develop and market new medicines

Author : Saipriya Iyer | Published Date : 2020-01-11 

Hikma Pharmaceuticals, a renowned UK based biopharmaceutical company, and Arecor, a biopharmaceutical firm advancing today’s treatments to enable healthier lives, have reportedly signed a new strategic agreement to develop a novel injectable medicine in the U.S. from Hikma’s subsidiary, Hikma Pharmaceuticals USA Inc.

The new product, which would be unveiled before launch, is being developed utilizing Arestat™, a proprietary drug formulation technology platform of Arecor. Arestat improves the characteristics of authorized therapeutic peptides and proteins to provide new reformulations of complex, existing products.

Hikma would seek authorization for this product under the U.S. FDA’s (Food and Drug Administration) 505(b)(2) regulatory pathway. The filing is expected to take place in 2021.

President of Hikma Injectables, Riad Mishlawi stated that the company is thrilled to enter this collaboration with Arecor. This is one more vital step ahead for Hikma in developing and marketing complex medicines as well as delivery systems that help patients and position the company’s business for seamless long-term growth.  

Mishlawi further added that the company is confident that this innovative development platform of Arecor, together with Hikma’s robust production capabilities and outstanding commercial team, with its strong connections across US hospital systems, would bring a vital new therapy option to healthcare providers and patients.

Chief Executive Officer of Arecor, Sarah Howell stated that the company is proud to be operating with Hikma. The company has an outstanding track record in developing RTU (ready-to-use) and RTA (ready-to-administer) medicines. These medicines have become increasingly important in order to enable safe, fast and effective therapy of patients. 

Howell further added that Hikma has a respected and robust US hospital industry presence. The company is also focused at providing cost-effective treatments that advance the delivery of medication and enhance patient care. The company now looks forward to the combined development of this initial product as a part of the wide collaboration with Hikma.

 

Source credit: https://www.hikma.com/newsroom/article-i4639-hikma-and-arecor-announce-exclusive-agreement-to-develop-and-commercialise-ready-to-use-medicine-using-arestat-technology/

About Author

Saipriya Iyer

Saipriya Iyer

Saipriya Iyer presently works as a content developer for fractovia.org. Having dabbled with the domain of content creation for nearly half a decade, she now boasts of an enviable portfolio, holding substantial experience in penning down pieces related to technology, finance, and a wide spectrum of other industry verticals. A qualified computer engineering graduate from the University of Pune, Saipriya can often be found leveraging her knowledge of software technology and electronics in her write-ups. She can be contacted at- [email protected] | https://twitter.com/saipriya_i

Related News

Food delivery firm Swiggy raises $43M to foray into new businesses

Published Date: 2020-04-07         Author: Saipriya Iyer

Swiggy, a renowned Indian food delivery company, reportedly announced that it secured another $43 million in a new investment round, which is a part of a series round that started in February, as the company looks towards its expansion to new businesses.  Existing investor of the company, Te... Read More

Boeing extends facilities shutdown in Seattle due to COVID-19 fear

Published Date: 2020-04-06         Author: Saipriya Iyer

The Boeing Company has recently announced the continuation of the production facilities shutdown in Seattle due to the rising fear of coronavirus outbreak. The company has reportedly informed the employees in Washington about the extension of the 2-week shutdown at the Seattle facility, which was pr... Read More

TWU accuses Qantas of inactivity as more worker test COVID-19 positive

Published Date: 2020-04-02         Author: Saipriya Iyer

The union for airline baggage holders, TWU (Transport Workers’ Union), has reportedly accused Qantas Airways, the largest Airline network of Australia, of not ensuring worker safety against COVID-19 after the company’s baggage handlers tested positive for coronavirus. The Union stated... Read More

© 2020 Fractovia. All Rights Reserved